This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
14 Apr 2020

Nektium's botanical ingredient Zynamite granted US patent for brain-enhancing activities

Nektium's botanical ingredient Zynamite granted US patent for brain enhancing activities. (PRNewsfoto/Nektium)

Zynamite is an all-natural evidence-based nootropic and sports performance ingredient, supported by clinical studies.

The United States Patent and Trademark Office has granted Nektium, a research-based branded botanical ingredient manufacturer based in Spain, a patent for its Compositions for Enhancing Brain Activity.

This patent is part of the intellectual property portfolio supporting Nektium's innovative ingredient Zynamite, a caffeine-free botanical ingredient for mental and physical energy. Zynamite is a sustainable, proprietary standardized extract of leaves of a selection of Mangifera indica, the mango tree.

The caffeine-free and doping-free nootropic activities of Zynamite have been appearing in diverse finished product innovations including popular smart supplements and egaming formulations in Japan.

Recognising the fundamental importance of the mind in sports performance, Nektium applied the brain-activating activities of Zynamite to sports formulations, which have been subjected to four double-blind, randomised controlled clinical trials. The positive results of these sports performance and recovery studies have been published in four peer-reviewed papers.

"The currency of the nutraceutical ingredient industry is scientific evidence obtained from double-blind, randomised controlled clinical studies conducted by reputable academic departments and CROs, and published in leading peer-reviewed journals. Nektium has made a major investment in the clinical research backing Zynamite and continues to invest in ongoing clinical studies," said Dr Nigel Gericke, Nektium's Director of Science. "Our intention is to keep building the clinical research base and intellectual property supporting Zynamite as a premium branded ingredient."

Zynamite was first launched at Vitafoods in Geneva and HI Japan in Tokyo in 2018 and at Supply Side West in the USA in 2019.

The nutraceutical industry has already recognized the clinical research and innovation behind Zynamite awarding the ingredient five awards in the last 2 years: the Nutraingredients Award for sports ingredient of the year in 2018, the Nutraingredients Award for research in 2019, the Frost & Sullivan Award for innovation in 2019, and the European Specialised Sports Nutrition Awards for the 2019 best 'free from' ingredient, and the 2019 runner up award for game-changer ingredient of the year.

Related News